Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December Starts With a Mixed Market | Live Stock
Cracking The Code: Understanding Analyst Reviews For Stryker
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Stryker Raised to Overweight From Equal-Weight by Morgan Stanley
Stryker Analyst Ratings
Morgan Stanley Initiates Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $445
Wednesday Ends With Index Decline | Wall Street Today
Do Options Traders Know Something About Stryker (SYK) Stock We Don't?
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
S&P 500, Dow Hit Records Right After Open | Live Stock
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Piper Sandler Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $420
The Returns At Stryker (NYSE:SYK) Aren't Growing